Press Release: Sports Medicine & Orthopaedic Center (SMOC) Among First Pain Clinics in Virginia to Use Non-Opioid Treatment for Patients with Chronic Pain

Sports Medicine & Orthopaedic Center (SMOC),  Among First Pain Clinics in Virginia to Use Non-Opioid Treatment for Patients with Chronic Pain

Spectra WaveWriter™ Spinal Cord Stimulator System allows patients to combine therapeutic options and customize treatment.  

Chesapeake, VA, March 7, 2018 – Sports Medicine & Orthopaedic Center (SMOC), is among the first pain clinics in Virginia to offer the Spectra WaveWriter™ Spinal Cord Stimulator System to patients with chronic pain. It’s the first and only system approved by the FDA to simultaneously provide paresthesia-based and sub-perception stimulation, two therapies used in providing pain relief. Paresthesia-based therapy provides pain relief with a light tingling sensation while sub-perception therapy works without that sensation.

“With the Spectra WaveWriter System we are able to achieve better pain coverage in areas that were difficult in the past.  Several of the patients that we have trialed have received 80% or better pain relief, which is amazing!” Dr. Victor Tseng.

 

Spinal cord stimulation (SCS) is an FDA approved non-opioid treatment option for people with chronic pain in the legs and back. The device sends low electrical pulses to the spinal cord that interrupt pain signals.  Two thin wires, called leads, are implanted in the spine and powered by a rechargeable battery which is implanted in the chest.

With the Spectra WaveWriter System, patients can combine both of these therapies to target one specific area of pain or use each therapy as needed to best manage multiple areas of pain. Patients provide real-time feedback using the system’s remote control. The Spectra WaveWriter System was developed with more than a decade of clinical research focused on optimizing sub-perception stimulation and delivering multiple therapies intended for more effective, long-term pain relief.

“The Spectra WaveWriter  System is really a game changer in our ability to treat patients.  It has broadened our scope for who we can treat.  Moreover, its provides the patient the opportunity to take back control of their pain without reliance on medications.”  Dr. Michael Ingraham

 

More than 100 million Americans suffer from chronic pain and it is the number one cause of disability in adults in the U.S.1,2 SCS was introduced more than 40 years ago. Unlike most surgical procedures, it is reversible. Patients undergo a trial period allowing them to evaluate it before deciding to receive a permanent implant.

To learn more, please visit SMOC-PT.com or ControlYourPain.com.

CONTACT:

Elizabeth Ruiz
Office Manager, SMOC Chesapeake Location, for Dr. Tseng
757-547-5145 ext. 3206
eruiz@smoc-pt.com

Jamie Gray
Suffolk Patient Care Coordinator for Dr. Ingraham
757-547-5145 ext 4322
jgray@smoc-pt.com

###

About Sports Medicine & Orthopaedic Center (SMOC)

Sports Medicine & Orthopaedic Center (SMOC) has been providing quality orthopaedic services to southeastern Virginia for more than 34 years. Each member of this highly distinguished practice is fellowship-trained in their respective areas of expertise and participates in the activities of numerous prestigious medical associations. SMOC was founded in 1984 and today includes specialty-trained orthopaedic, spine and pain medicine physicians, specialty trained physician assistants and physical and occupational therapists specializing in orthopaedic services, joint care and pain medicine.

1https://www.cdc.gov/drugoverdose/epidemic/index.html

2Institute of Medicine. Relieving pain in America: a blueprint for transforming prevention, care, education and research. Washington, DC: National Academies Press, 2011.

Sub-perception stimulation has been demonstrated to be safe and effective in patients who have been treated successfully with conventional, paresthesia-inducing stimulation for at least six months. Full stimulation parameter ranges and options for both paresthesia-based and sub-perception therapy are available for clinician’s use throughout the patient’s experience and treatment with SCS.

Indications for Use: The Boston Scientific Spinal Cord Stimulator Systems are indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs including unilateral or bilateral pain associated with the following: failed back surgery syndrome, Complex Regional Pain Syndrome (CRPS) Types I and II, intractable low back pain and leg pain. Associated conditions and etiologies may be: radicular pain syndrome, radiculopathies resulting in pain secondary to failed back syndrome or herniated disc, epidural fibrosis, degenerative disc disease (herniated disc pain refractory to conservative and surgical interventions), arachnoiditis, multiple back surgeries. Contraindications, warnings, precautions, side effects. The SCS Systems are contraindicated for patients who: are unable to operate the SCS System, have failed trial stimulation by failing to receive effective pain relief, are poor surgical risks, or are pregnant. Refer to the Instructions for Use provided with the SCS System or ControlYourPain.com for potential adverse effects, warnings, and precautions prior to using this product. Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

SaveSaveSaveSave

Recent Posts

Start typing and press Enter to search